StockVS

So-Young International Inc. (SY) 주식 분석

의료

So-Young International Inc.

$2.20

$-0.03 (-1.35%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

So-Young International Inc. operates primarily as a provider of consumption healthcare services within the People's Republic of China, utilizing a dedicated online platform to deliver medical aesthetic knowledge, community support, and treatment reservation options for medical professionals. The company functions within the Healthcare sector, specifically categorized under the Health Information Services industry, which implies a business model focused on digital connectivity and service delivery rather than traditional pharmaceutical manufacturing or hospital operations. As of the latest data, the company holds a market capitalization of $287.62 million and reports total annual revenue of $1.52 billion, though specific employee headcount information is not publicly disclosed. These valuation and revenue figures indicate that So-Young International Inc. is a mid-sized enterprise with significant top-line generation capabilities relative to its market cap, suggesting a potential for high growth or specific valuation adjustments common in the technology-driven healthcare services sub-sector.

재무 건전성

So-Young International Inc. reported a trailing twelve-month revenue of $1.52 billion alongside a net income loss of -$242,300,992 and an EBITDA of -$220,548,992, revealing a substantial gap between top-line generation and bottom-line profitability. This significant disparity between revenue and net income indicates a cost structure where operating expenses, likely including customer acquisition costs for its mobile app and medical professional network, currently exceed gross margins to the extent that the company operates at a pre-tax and post-tax loss. While the company reports cash assets totaling $871.68 million, free cash flow data is not available in the current reporting period, which limits the immediate assessment of operational cash generation but suggests reliance on cash reserves for liquidity management. The company maintains a gross margin of 47.8%, reflecting the high cost of revenue associated with service delivery, while the operating margin stands at -22.4% and the profit margin at -15.9%, signaling that overhead costs and general administrative expenses are eroding profitability across the entire business. On the balance sheet, the company holds $871.68 million in cash against total debt of $299.71 million, resulting in a debt-to-equity ratio of 17.96, which indicates a highly leveraged position relative to equity financing despite the absolute dollar amount of cash on hand. The current ratio of 1.89 suggests adequate short-term liquidity to cover current liabilities, yet the negative return on equity of -13.6% and return on assets of -6.2% demonstrate that management is currently not generating positive returns on the capital invested in the company.

밸류에이션 평가

Valuation metrics for So-Young International Inc. present a complex picture, with a trailing P/E ratio listed as not available due to losses, while the forward P/E is reported at -11.76, implying that expected earnings are anticipated to remain negative in the near term. The price-to-book ratio stands at 1.28, indicating that the market values the company's equity at a 28% premium over its book value, a metric often seen in asset-light or high-growth service companies despite current losses. Alternative valuation measures include a price-to-sales ratio of 0.19 and an EV/EBITDA of 1.07, suggesting that the stock is priced very low relative to its revenue base, which may reflect market skepticism regarding the sustainability of its current loss-making trajectory. The stock has exhibited significant volatility, trading between a 52-week high of $6.28 and a 52-week low of $0.67, placing the current trading price in a range that reflects substantial downward pressure from recent market movements. With a beta of 2.17, the company's stock price is expected to be more than twice as volatile as the broader market, meaning that price swings will likely be amplified during periods of general market turbulence.

Growth & Income

So-Young International Inc. demonstrated robust top-line expansion with a year-over-year revenue growth rate of 24.8%, whereas earnings growth is not available due to the reported net losses, indicating that while the business is scaling rapidly, profitability has not yet kept pace with revenue expansion. As the company does not pay a dividend, the dividend yield is not applicable and the payout ratio is 0.0%, meaning that all available cash flows are theoretically available for reinvestment into the business rather than being distributed to shareholders. This reinvestment strategy is typical for growth-stage companies in the health information services sector that prioritize market share acquisition and platform development over immediate shareholder returns. Overall, the growth profile is characterized by double-digit revenue expansion and a lack of current income distribution, positioning the company as a pure-play growth vehicle where capital appreciation is the sole mechanism for investor return.

동종업체 비교

So-Young International Inc. (SY) 은(는) 의료 정보 서비스 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
So-Young International Inc. SY $220.66M N/A
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

의료 정보 서비스 산업 평균 PER은 57.5배입니다. So-Young International Inc.의 PER은 N/A입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

So-Young International Inc. 소개

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$220.66M
PER
N/A
52주 최고가
$6.28
52주 최저가
$0.83
평균 거래량
530.70K

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NASDAQ
국가
China
직원 수
2,348